Harvest Fund Management Co., LTD Seagen Inc. Transaction History

Harvest Fund Management Co., LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	BUY	$191.51 - $216.16 $493,138 - $556,612	2,575 Added 279.59%	3,496 $742,000
Q2 2023 Jul 07, 2023	BUY	$187.64 - $206.25 $81,060 - $89,100	432 Added 88.34%	921 $177,000
Q1 2023 May 10, 2023	BUY	$127.59 - $203.08 $29,218 - $46,505	229 Added 88.08%	489 $99,000
Q4 2022 Feb 06, 2023	BUY	$117.37 - $139.17 $26,290 - $31,174	224 Added 622.22%	260 $33,000
Q3 2022 Nov 10, 2022	BUY	$135.27 - $180.11 $4,869 - $6,483	36 New	36 $5,000
Q1 2021 May 13, 2021	SELL	$137.51 - $190.8 $74,530 - $103,413	-542 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$164.63 - $211.93 $33,913 - $43,657	-206 Reduced 27.54%	542 $94,000
Q3 2020 Nov 04, 2020	BUY	$145.95 - $195.69 $109,170 - $146,376	748 New	748 $151,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Harvest Fund Management Co., LTD, based on Form 13F filings with the SEC.

Stay updated on Harvest Fund Management Co., LTD with notifications on news.